The Operations and Development Strategy of Original Pharmaceutical Manufacturer - a Case Study of P Company

• Main Authors: LEE, CHIH-WEI, 李智維
• Other Authors: 蕭堯仁
• Format: Others
• Language: zh-TW
• Published: 2013
• Online Access: http://ndltd.ncl.edu.tw/handle/39xb9m

碩士 === 逢甲大學 === 經營管理碩士在職專班 === 102 === Taiwan pharmaceutical factories in Taiwan must passing PIC/S GMP criteria before Dec-31th 2014. The NHI Administration adjust firstly by 「three same policy」 to the three B items payment price of NHI from 1-st-July in 2014. It will much effectively to the original pharmaceutical. This study for the individual case property situation analyze and by the SWOT for study to pharmaceutical key successful factors for management and development in the future. Then it ducts the individual case company into special competition ability to propose related management strategy suggestion for company development in the future. Analyzing the result suggest to P company management and development strategy as following： 1. Quickly Diabetics, Anti-virus, Oncology, Rheumatoid Arthritis（RA） and Vaccine, the five category products launch. 2. Raising self-provided market products earning proportion including LOE and OTC products. 3. By way of the same trade cooperation and inner cost control reduce the whole operation cost. In the whole pharmaceutical marketing developing strategy establish should be certainly reference value, to offer the same trade and follow-up study related reference.